Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0365719950110010067
Journal of Pusan Surgical Society
1995 Volume.11 No. 1 p.67 ~ p.83
Port for the Primry Hepatocellular Carcinoma and Metastatic Tumors of the Liver : Preliminary Report of 10 Cases
¼±º´È£
¾Èº´±Ç/±èº´¼ö/±è¸¸±â.
Abstract
TAE has been widely used to manage the patients with primary HCC or metastatic tumors the liver, but it has been so limited to be performed only at well equipped large hospitals that most of those patients could not have chances to be managed.
Without aids of angiography, authors performed transarterial Chemo-lipiodolizations though the surgically implanted ports in 8 patients who had HCC or metastatic tumors of the liver and adjunctive transportal Chemolipiodolizations in 2 advanced
rectal
cancer patients who showed no evidence of liver metastases. According to the purposes, 6 palliative embolizations for unresectable liver lesions and 4 adjunctive embolizations along the principles of multimodality therapy were performed.
Postoperatively, not only catheter related complications, such as misperfusion to the spleen and partial perfusion of the liver, but also chemoembolization related complications, such as gastroducdenal erosion, liver failure, liver necrosis, and
spleen
infarction appeared. On serial post-embolization CT scans, at least more than 50 per cent reduction of tumor size was recognized in 6 cases who revealed unresectable tumors in the liver.
Authors consider that correct surgical catherization and port implantation in the time of operation, that is required for primary malignant lesions or other intra-abdominal problems than unresectable liver tumor itself, 1) could alleviate the
risk
of
repeated catheterizations, 2) could afford another effective way of management as TAE does, 3) could afford more chances to treat much more numbers of patients and to overcome the limitations of TAE, and 4) the time intervals longer than 2 months
of
repeated Lipiodol chemo-embolization would be better to avoid complications such as liver necrosis and liver failure in patients with advanced cirrhosis.
KEYWORD
FullTexts / Linksout information
Listed journal information